Veraxa Biotech Holding AG (VRXA) Cash & Current Investments (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has 2 years of Cash & Current Investments data on file, last reported at $1.5 million in Q4 2025.

• On a quarterly basis, Cash & Current Investments fell 75.91% year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $1.5 million, a 75.91% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 75.91% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $1.5 million, down from $6.3 million in the prior quarter.
• Over the last five years, Cash & Current Investments for VRXA reached as high as $6.3 million in Q4 2024 and fell as low as $1.5 million in Q4 2025.